[Healthy pharmaceutical policy].
Today, the pharmaceutical industry is experiencing a profound transition. Globalization and technological advancement represent the principal pressures for change in the market, where it is increasingly more difficult for this type of industry to efficiently recoup the growing cost of innovation. Mexico needs to analyze the policy implications of these change factors and promote, in the pharmaceutical market, policies that maximize health gains on invested resources. Pharmaceutical policy offers a rare example for a complementary approach between a sound health policy and an efficient economic policy; that is, a "healthy pharmaceutical policy."
González Pier
Eduardo
E
Unidad de Análisis Económico, Secretaría de Salud, México. egpier@gmail.com
D017277:Drug Approval / Q000191:economics; D016527:Drug Costs; D055808:Drug Discovery / Q000191:economics; D004345:Drug Industry / Q000191:economics / Q000639:trends; D004467:Economics; D006291:Health Policy; D040541:Marketing; D008800:Mexico; D004364:Pharmaceutical Preparations / Q000191:economics; D035703:Therapies, Investigational
D004364:Pharmaceutical Preparations